The growing use of artificial intelligence (AI) in healthcare has sparked new concerns among physicians, regulators, and patient advocates. In response, the American Medical Association (AMA) recently adopted policies designed to ensure that AI remains a support tool rather than a replacement for physician judgment. The new policies specifically target AI-driven prior authorization and clinical decision support systems, emphasizing transparency, accountability, and physician oversight.
As healthcare organizations increasingly adopt AI technologies to improve efficiency, the AMA believes safeguards are necessary to protect patient care. The organization argues that healthcare decisions should always involve qualified physicians, regardless of how advanced AI systems become.
Why the AMA Is Concerned About AI in Prior Authorization
Prior authorization has long been a contentious issue in healthcare. Insurers require providers to obtain approval before certain treatments, procedures, or medications can be covered. While AI promises to streamline this process, many physicians worry that automated systems could deny or delay medically necessary care without adequate human review.
According to a recent AMA survey, 61% of physicians expressed concern about health insurers’ growing reliance on AI for prior authorization decisions. Many clinicians fear that unregulated AI tools could increase denials and create additional barriers for patients seeking treatment.
Furthermore, critics argue that opaque AI systems often function as “black boxes,” making it difficult for physicians and patients to understand why a request was denied. As a result, appeals and treatment delays can become more common.
New Policies Adopted by the AMA
AI-Based Coverage Decisions
The AMA House of Delegates approved a policy that establishes stronger safeguards for AI-assisted coverage determinations. Under the policy, insurers should rely on current, evidence-based medical information when using AI tools. More importantly, physicians must review coverage decisions before they affect patient care.
The policy also opposes the use of autonomous or semi-autonomous AI systems that replace physician review during coverage determinations. Instead, AI should support healthcare professionals rather than operate independently.
Additionally, the AMA plans to advocate for:
Greater Transparency
Health plans should clearly explain how AI systems reach decisions, what data sources they use, and whether a physician reviewed the outcome. This transparency can help build trust and reduce confusion among providers and patients.
Physician-Led Decision Making
The organization wants regulations that require AI tools to be integrated into physician-led workflows. Consequently, clinicians would retain ultimate responsibility for patient care decisions.
AI-Powered Clinical Decision Support
The AMA also introduced policies addressing AI-driven clinical decision support tools. These systems assist physicians by analyzing patient data and recommending treatment options.
However, the organization insists that such tools must adhere to evidence-based medicine principles. Therefore, the AMA will collaborate with specialty societies, regulators, AI developers, and healthcare stakeholders to establish standards for:
Evidence Attribution
AI recommendations should clearly identify the medical evidence supporting each conclusion.
Validation and Evaluation
Developers must continuously test AI tools to ensure accuracy, reliability, and clinical relevance.
Transparency and Explainability
Healthcare providers should understand how AI systems generate recommendations. Clear explanations can improve trust and facilitate better clinical decisions.
Routine Auditing
The AMA supports annual reviews and additional audits whenever significant changes occur in AI models, training datasets, or clinical guidelines. These evaluations can identify potential risks before they impact patient care.
The Growing Debate Around AI in Healthcare
AI continues to transform healthcare operations. Many organizations use AI for documentation, predictive analytics, administrative workflows, and prior authorization processes. At the same time, concerns about algorithmic bias, transparency, and patient safety continue to grow.
Research suggests that large language models can perform well on certain healthcare tasks. Nevertheless, experts agree that AI cannot independently practice medicine or replace clinical judgment. Human oversight remains essential, particularly when treatment decisions affect patient outcomes.
Moreover, several healthcare stakeholders have questioned whether insurers are using AI primarily to reduce administrative costs rather than improve patient care. These concerns have intensified calls for stronger regulatory oversight.
Impact on Physicians and Patients
The AMA believes that physician oversight is critical for maintaining high-quality patient care. Without proper safeguards, AI-driven denials could delay treatments, increase administrative burdens, and create additional frustration for both providers and patients.
For patients, the stakes are particularly high. Delays in treatment approvals can lead to worsened health outcomes and reduced access to necessary medical services. Consequently, many healthcare leaders support a balanced approach that leverages AI efficiency while preserving physician accountability.
Future of AI Governance in Healthcare
Looking ahead, AI will likely play an even larger role in healthcare administration and clinical operations. However, the AMA’s new policies signal a broader industry effort to ensure that technological innovation does not outpace patient protections.
As regulators, healthcare providers, insurers, and technology developers continue to refine AI governance frameworks, physician oversight is expected to remain a central requirement. The goal is not to halt AI adoption but to ensure that these tools enhance healthcare delivery without compromising patient safety.
Conclusion
The AMA’s latest policy actions reflect growing concerns about the use of AI in prior authorization and clinical decision-making. By advocating for transparency, regular audits, evidence-based standards, and physician-led oversight, the organization aims to ensure that AI serves as a valuable healthcare tool rather than an independent decision-maker. As AI adoption accelerates across the healthcare industry, maintaining accountability and protecting patient interests will remain top priorities.
